Skip to content Skip to main navigation Report an accessibility issue

Funding Opportunities


To sign up for the digest, click here.

NIH Opportunities

Join the UT NIH Research Community by contacting Jennifer Webster (jwebster@utk.edu) and start receiving the weekly NIH Digest.

  • NIH Standard Deadlines for Investigator-Initiated Research Projects
  • NCI Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) (PAR-18-559)
  • NCI National Cancer Institute’s Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required) (PAR-18-560)
  • NIAAA Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 – Clinical Trials Optional) (PAS-18-557)
  • NIDCD Clinical Research Center Grant (P50 – Clinical Trials Optional) (PAR-18-556)
  • NIMH Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional) (PAR-18-554)
  • NIMH Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01) and Clinical Trial Optional (PAR-18-555)

To sign up for the digest, click here.

Federal Opportunities

Please contact Paul Montgomery (paul.montgomery@utk.edu) regarding your interest in federal opportunities.

DoD recently published the attached solicitation entitled Defense Enterprise Science Initiative. DESI is a new program that supports use-inspired basic research performed by university-industry teams in order to accelerate the impact of knowledge on key defense challenges and on DoD acquisition programs.

DESI is seeking proposals on the following 4 specific topics:

  • Power Beaming
  • Hihly-maneuverable autonomous UAV
  • Soft Active Composites with Intrinsic Sensing, Actuation, and Control
  • Metamaterial-based Antennas

The proposal deadline is 28 Feb 2018.  DoD anticipates making 4 awards of $750K annually for a period of 2 years, with an option for a third year of additional funding.  Note that each proposal must include at least 1 university and 1 industry member, and the university partner must receive at least 50% of requested funding.  Also note that not every topic above will necessarily be granted an award.

NIH Opportunities

Join the UT NIH Research Community by contacting Jennifer Webster (jwebster@utk.edu) and start receiving the weekly NIH Digest.

  • NIH Standard Deadlinesfor Investigator-Initiated Research Projects
  • NIH BRAIN Initiative: Biology and Biophysics of Neural Stimulation (R01 – Clinical Trials Optional)(RFA-NS-18-018)
  • NIH BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR)(R43/R44 Clinical Trial Not Allowed)(PAR-18-501)
  • NIH BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR)(R41/R42 Clinical Trial Not Allowed)(PAR-18-515)
  • NIH BRAIN Initiative: Targeted BRAIN Circuits Planning Projects Targeted BCPP (R34 – Clinical Trials Not Allowed)(RFA-NS-18-014)
  • NIH Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed)(PA-18-504)
  • NIH Advancing the Science of Geriatric Palliative Care (R01 – Clinical Trial Optional)(PA-18-502)
  • NIH Advancing the Science of Geriatric Palliative Care (R21 – Clinical Trial Optional)(PA-18-503)
  • NCCIH Discovery and Biological Signatures of Diet Derived Microbial Metabolites (R01 Clinical Trial Optional)(RFA-AT-18-003)
  • NCI Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the PDX Development and Trial Centers Research Network (PDXNet)(Admin Suppl – Clinical Trial Not Allowed)(PA-18-496)
  • NCI Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional)(PA-18-492)
  • NCI Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional)(PA-18-493)
  • NHLBI Deciphering the Molecular Landscape of Lung Aging in Humans (U01 – Clinical Trial Not Allowed)(RFA-HL-19-012)
  • NIA From Association to Function in the Alzheimer’s Disease Post-Genomics Era (R01 – Clinical Trial Not Allowed)(RFA-AG-18-026)
  • NIA Exosomes: From Biogenesis and Secretion to the Early Pathogenesis of Alzheimer’s Disease (R01 – Clinical Trial Not Allowed)(RFA-AG-18-027)
  • NIA Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimer’s Disease Risk (R01 – Clinical Trial Not Allowed)(RFA-AG-18-029)
  • NIA Pragmatic Trials of Managing Multimorbidity in Alzheimer’s Disease (R01 Clinical Trial Required)(RFA-AG-18-028)
  • NIA Sleep disorders and circadian clock disruption in Alzheimer’s disease and other dementias of aging (R01 Clinical Trial Not Allowed)(PAR-18-497)
  • NIAAA Interaction of HIV Infection and Alcohol Abuse on Central Nervous System Morbidity Limited Competition (U01 Clinical Trial Not Allowed)(RFA-AA-18-008)
  • NIBIB Exploratory/Developmental Research Grant Program (R21) (Clinical Trial Optional)(PAR-18-433)
  • NIBIB Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional)(PAR-18-434)
  • NIDCD Early Career Research(ECR) Award (R21 – Clinical Trials Optional)(PAR-18-487)
  • NICHD Non-Invasive Diagnostics to Improve Gynecologic Health (R43/R44 – Clinical Trial Optional)(RFA-HD-19-006)
  • NICHD Studies in Neonatal and Pediatric Resuscitation (R01 Clinical Trial Optional)(PA-18-485)
  • NICHD Studies in Neonatal and Pediatric Resuscitation (R03 – Clinical Trial Optional)(PA-18-491)
  • NIDA Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional)(RFA-DA-19-002)
  • NIDA Device-Based Treatments for Substance Use Disorders (UG3/UH3) (Clinical Trial Optional)(PAR-18-494)
  • NIDCR Dental Specialty and PhD Program (DSPP)(K12-Clinical Trials Not Allowed)(RFA-DE-18-012)
  • NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00-Clinical Trial Required)(PAR-18-432)
  • NIDDK Academic Research Enhancement Award in Diseases within the Mission of NIDDK (R15 – Clinical Trial Required)(PA-18-495)
  • NIDDK / NCATS Microphysiological Systems (MPS) for Modeling Diabetes (UG3/UH3 Clinical Trial Not Allowed)(RFA-DK-17-035)
  • NEI Human Subjects Mechanistic and Minimal Risk Studies (R21 Clinical Trial Optional)(PA-18-500)
  • NINR End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R01 Clinical Trial Optional)(PA-18-498)
  • NINR End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R21 Clinical Trial Optional)(PA-18-499)

NSF Opportunities

Please contact Sharon Pound (spound@utk.edu) regarding your interest in NSF opportunities.

  • Critical Resilient Interdependent Infrastructure Systems and Processes 2.0 FY18 (CRISP 2.0) NSF 18-523

Dear Colleague Letters

  • ENG/CMMI Call for NSF Big Ideas Proposals NSF 18-029 Dec. 4, 2017
  • Delay in Issuance of Revised Program Solicitations for CEDAR, GEM, and SHINE  NSF 18-030 Dec. 8, 2017
  • Rules of Life (RoL): Forecasting and Emergence in Living Systems (FELS) NSF 18-031 Dec. 11, 2017
  • RAISE on Enabling Quantum Leap: Transformational Advances in Quantum Systems NSF 18-035 Dec. 14, 2017

paul.montgomery@utk.edu) regarding your interest in federal opportunities.

The Defense Advanced Research Projects Agency (DARPA) has published its Young Faculty Award (YFA) solicitation. This year’s YFA has 26 topics. Please be aware that your proposed research should offer “innovative approaches that enable revolutionary advances in science, devices, or systems.”

Proposers are encouraged to submit a 1-page executive summary by 4pm on October 2. The proposal deadline is 4pm on December 4. The estimated award is up to $500k over 2 years, optional third year for an additional $500k.

Continue reading


jwebster@utk.edu) and start receiving the weekly NIH Digest.

  • NIH Standard Deadlinesfor Investigator-Initiated Research Projects
  • NIH Roadmap Initiatives Metabolomics Core for the Undiagnosed Diseases Network (UDN) Phase II (U01)(RFA-RM-17-015)
  • NIH Roadmap Initiatives Sequencing Core(s) for the Undiagnosed Diseases Network (UDN) Phase II (U01)(RFA-RM-17-016)
  • NIH Roadmap Initiatives Model Organisms Screening Center for the Undiagnosed Diseases Network (UDN) Phase II (U54)(RFA-RM-17-017)
  • NIH Roadmap Initiatives Coordinating Center for the Undiagnosed Diseases Network (UDN) Phase II (U01)(RFA-RM-17-018)
  • NIH Roadmap Initiatives Clinical Sites for the Undiagnosed Diseases Network (UDN) Phase II (U01)(RFA-RM-17-019)
  • NIH BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01) (RFA-MH-18-500)
  • NIH Blueprint for Neuroscience Research: Dynamic Neuroimmune Interactions in the Transition from Normal CNS Function to Disorders (R01) (RFA-AA-18-007)
  • NIH Clinical and Epidemiological Research on Chronic Disease in the Caribbean (R01)(PAR-17-470)
  • NIH Limited Competition: Lasker Clinical Research Scholars Transition Award (R00) (PAR-17-450)
  • NCATS Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3)(PAR-17-465)
  • NCI Biology of Lung, and Head, and Neck Preneoplasias (R01)(PA-17-459)
  • NCI Biology of Lung, and Head, and Neck Preneoplasias (R21)(PA-17-460)
  • NCI Biology of Lung, and Head, and Neck Preneoplasias (R21)(PAR-17-460)
  • NCI Consortium on Translational Research in Early Detection of Liver Cancer (Clinical and Research Centers (U01)(RFA-CA-17-025)
  • NCI Coordinating Center for the Consortium of Translational Research in Early Detection of Liver Cancer (U24)(RFA-CA-17-028)
  • NCI / NHLBI Limited Competition: A Data Resource for Analyzing Blood and Marrow Transplants (U24)(RFA-CA-17-031)
  • NHLBI Continuation of Existing Grant Based Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01)(PAR-17-338)
  • NHLBI / NCI NIAID Stimulating Access to Research in Residency (StARR) (R38)(RFA-HL-18-023)
  • NIAAA Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies (Collaborative U01)(RFA-AA-18-002)
  • NIAAA Alcoholic Hepatitis Clinical and Translational Network Translational Research (U01)(RFA-AA-18-003)
  • NIAAA Alcoholic Hepatitis Clinical and Translational Network Data Coordinating Center (U24)(RFA-AA-18-004)
  • NIAAA Alcoholic Hepatitis Clinical and Translational Network Clinical Pilot Trials (U01)(RFA-AA-18-005)
  • NIAAA Alcoholic Hepatitis Clinical and Translational Network Basic and Pre-Clinical Research (UH2/UH3)(RFA-AA-18-006)
  • NIAAA Secondary Analyses of Existing Alcohol Research Data (R01) (PA-17-467)

Continue reading